Literature DB >> 21671364

Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer.

Hadir A El-Mahallawy1, Mohamed El-Wakil, Manar M Moneer, Lobna Shalaby.   

Abstract

PURPOSE: With the increasing emergence of multiresistant pathogens, better understanding of these infections is necessary. The aim of the present study was to evaluate the risk factors associated with isolating a multiresistant organism (MRO) from a positive blood culture in pediatric cancer patients with febrile neutropenia (F&N), and to study its impact on clinical course and outcome of febrile episodes. PATIENTS AND METHODS: The association between MRO with underlying malignancy, age, disease status, hospitalization during episode, absolute neutrophil count, absolute monocyte count, clinical foci of infection, and pathogens isolated was assessed in bacteremic pediatric cancer patients. The MRO phenotype was defined as diminished susceptibility to ≥3 of the broad spectrum antibody classes.
RESULTS: Among 239 episodes of blood stream infections (BSI), Gram-positive, and Gram-negative organisms were detected in 180 (75%), and 59(25%) episodes, respectively; with 38% of isolates showing multiresistance (n = 92). Significant risk factors (P < 0.05) for MRO were hospitalization, Gram-negative organisms, presence of clinical focus of infection, reduced ANC, prolonged duration of neutropenia, and previous intake of antibiotics. Of the episodes with prolonged duration of fever extending for more than 7 days 62% (64|93) were associated with a multiresistant phenotype, while it accompanied 72% (18|25) of the cases with an unfavorable outcome; P-value <0.001.
CONCLUSION: Isolation of MRO is more likely to be associated with a prolonged course and an unfavorable outcome. Continuous multidisciplinary surveillance of BSI is warranted to develop strategies for antimicrobial resistance control.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21671364     DOI: 10.1002/pbc.22926

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  20 in total

Review 1.  Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.

Authors:  A Manji; J Beyene; L L Dupuis; R Phillips; T Lehrnbecher; L Sung
Journal:  Support Care Cancer       Date:  2012-03-09       Impact factor: 3.603

2.  Extended Infusion of Piperacillin/Tazobactam in Children.

Authors:  Chad A Knoderer; Lauren C Karmire; Katie L Andricopulos; Kristen R Nichols
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

3.  Effect of Nigella sativa seed administration on prevention of febrile neutropenia during chemotherapy among children with brain tumors.

Authors:  HebatAlla Fathi Mohamed Mousa; Nesrin Kamal Abd-El-Fatah; Olfat Abdel-Hamid Darwish; Shehata Farag Shehata; Shady Hassan Fadel
Journal:  Childs Nerv Syst       Date:  2017-03-27       Impact factor: 1.475

Review 4.  Granulocyte transfusions: A concise review for practitioners.

Authors:  Juan Gea-Banacloche
Journal:  Cytotherapy       Date:  2017-09-12       Impact factor: 5.414

5.  Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.

Authors:  R A Ammann; H J Laws; D Schrey; K Ehlert; O Moser; D Dilloo; U Bode; A Wawer; A Schrauder; G Cario; A Laengler; N Graf; R Furtwängler; A Simon
Journal:  Eur J Pediatr       Date:  2015-03-26       Impact factor: 3.183

6.  Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience.

Authors:  D Averbuch; C Avaky; M Harit; P Stepensky; I Fried; T Ben-Ami; V Temper; Y Peled; H Troen; R Masarwa; W Abu Ahmad; M Weintraub; S Revel-Vilk; D Engelhard
Journal:  Infection       Date:  2017-02-15       Impact factor: 3.553

7.  Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia.

Authors:  Youn-Jung Kim; Sung Min Jung; Jihoon Kang; Seung Mok Ryoo; Chang Hwan Sohn; Dong-Woo Seo; Kyoung Soo Lim; Jin Won Huh; Sung-Han Kim; Won Young Kim
Journal:  Intern Emerg Med       Date:  2019-01-01       Impact factor: 3.397

8.  Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.

Authors:  Thomas H Price; Michael Boeckh; Ryan W Harrison; Jeffrey McCullough; Paul M Ness; Ronald G Strauss; W Garrett Nichols; Taye H Hamza; Melissa M Cushing; Karen E King; Jo-Anne H Young; Eliot Williams; Janice McFarland; Jennifer Holter Chakrabarty; Steven R Sloan; David Friedman; Samir Parekh; Bruce S Sachais; Joseph E Kiss; Susan F Assmann
Journal:  Blood       Date:  2015-09-02       Impact factor: 22.113

9.  Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns.

Authors:  Karin G E Miedema; Rik H L J Winter; Roland A Ammann; Sara Droz; Lodewijk Spanjaard; Eveline S J M de Bont; Willem A Kamps; Marianne D van de Wetering; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2013-04-12       Impact factor: 3.603

10.  Optimized antimicrobial dosing strategies: a survey of pediatric hospitals.

Authors:  Chad A Knoderer; Kristen R Nichols; Elaine G Cox
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.